AKBA vs AWK · rev $160.2M vs P/E 22, rev $4.65B
Akebia Ther (AKBA) versus American Water Works (AWK) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Latest reported AKBA revenue for 2024-12-31 was $160.2M. Net income was -$69.4M. Revenue was down 17.7% from 2023-12-31 to 2024-12-31. AKBA currently screens at market cap $260.1M.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
AKBA currently screens at market cap $260.1M. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Not investment advice. Open the AKBA and AWK stock pages for the full models.
Not investment advice.